IP Library Granted Patent US 7,378,086
Granted Patent B2
US 7,378,086 · App. 10/935,905 · Granted May 27, 2008

Retroviral vector having an ovalbumin promoter

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,378,086
App. No.
10/935,905
Granted
May 27, 2008
Kind
B2
Abstract

Vectors and methods are provided for introducing genetic material into cells of a chicken or other avian species. More particularly, vectors and methods are provided for transferring a transgene to an embryonic chicken cell, so as to create a transgenic hen wherein the transgene is expressed in the hen's oviduct and the transgene product is secreted in the hen's eggs and/or those of her offspring. In a preferred embodiment, the transgene product is secreted in the egg white.

Claims (4)

1. A replication-defective retroviral vector, comprising:

a) a transgene; and

b) control elements operably-linked to the transgene, wherein the control elements comprise an ovalbumin promoter comprising nucleotides 284-1619 of SEQ ID NO: 1, an SV40 enhancer, three estrogen response elements, an ovalbumin gene 5′ untranslated region, and an egg white lysozyme signal sequence.

2. The vector of claim 1 , wherein the replication-defective retroviral vector is derived from REV-A.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2016
From: ALEXION PHARMA LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 039934/0687 →
MERGER AND CHANGE OF NAME Recorded Jun 17, 2016
From: SYNAGEVA BIOPHARMA CORP.; GALAXY MERGER SUB LLC
To: ALEXION PHARMA LLC
Reel/Frame 038946/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2016
From: GALAXY MERGER SUB LLC
To: ALEXION PHARMA LLC
Reel/Frame 037872/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2009
From: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
To: SYNAGEVA BIOPHARMA CORP.
Reel/Frame 022482/0994 →